Clinical investigation: a temporal relationship exists between hd therapy utilizing the unknown hd system and the adverse events of hypovolemia, hypotension, loss of consciousness, and dyspnea.Per the patient, the serious adverse events occurred due to removing to much fluid.Given the limited information provided, the patient likely experienced an episode of intradialytic hypotension due to hypovolemia.Hypotension is the most prevalent complication associated with hd and occurs in approximately 25% of all treatments.Very often, the cause of the hypotension is multifactorial.Based on the information available, the unknown 2008 system can be disassociated from the event(s).There is no allegation or objective evidence indicating a fresenius device(s) and/or product(s) deficiency or malfunction caused or contributed to the serious adverse events.Plant investigation: the device was not returned to the manufacturer for physical evaluation and the serial number could not be obtained.As a serial number could not be determined, device history and manufacturing records could not be reviewed.As a physical evaluation could not be performed, a definitive conclusion regarding the reported incident could not be reached and a cause could not be confirmed.
|
Fresenius became aware (via a customer experience survey) this unknown patient with end stage renal disease (esrd) previously on hemodialysis (hd) for renal replacement therapy (rrt) experienced an episode of intradialytic hypotension (systolic blood pressure 50¿s).The patient reportedly ¿passed out¿ (loss of consciousness) after too much fluid was removed (hypovolemia) and was found ¿gasping for breath¿ (dyspnea).Knowledge of the serious adverse events was obtained from a customer experience survey, in which the patient chose to remain anonymous.As such, written or telephonic follow-up was not possible.
|